New generation anaplastic lymphoma kinase inhibitors

Anaplastic lymphoma kinase (ALK) gene translocations are pro-tumoral driver alterations that encompass 3–7% of non-squamous non-small cell lung cancer (NSCLC) with specific, clinic and histologic features. The therapeutic strategy depends on anti-ALK tyrosine kinase inhibitors (TKIs) of which crizot...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Lung Cancer Res
Hlavní autoři: Delmonte, Angelo, Burgio, Marco Angelo, Verlicchi, Alberto, Bronte, Giuseppe, Cravero, Paola, Ulivi, Paola, Martinelli, Giovanni, Crinò, Lucio
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2019
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894988/
https://ncbi.nlm.nih.gov/pubmed/31857951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.09.14
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky